Regulatory Compliance

St. Johns County Preps $191.6M Tax Revenue Hit From Amendment 3

Image
St. Johns County Preps $191.6M Tax Revenue Hit From Amendment 3

St. Johns County, Fla. – September 17, 2026 -- St. Johns County has built a fiscal contingency plan around estimates showing property-tax revenue could fall by $68.3 million in Fiscal Year 2028, $136.1 million in FY 2029, and $191.6 million in FY 2032 if voters approve Property Tax Amendment 3 on Nov. 3, 2026. The projections, sourced from the Florida Office of Economic and Demographic Research, have driven a countywide budget review underway since May.

County identifies $108.6 million in spending for post-election reassessment

Staff flagged approximately $100 million in capital improvement projects for hold status, alongside $4 million tied to vacant positions, $2 million in unfunded FY 2027 roles, and $2.6 million in paused-but-recommended positions. County Administrator Joy Andrews said the approach lets officials avoid committing resources that may not be available later while protecting long-term financial stability.

AdJane Unveils Nm-nOMV Mucosal Booster for Respiratory Vaccine Franchises

Image
AdJane Unveils Nm-nOMV Mucosal Booster for Respiratory Vaccine Franchises

Delft, Netherlands – September 17, 2026 -- AdJane Biosciences has published a technical white paper detailing a strategy to add a proprietary mucosal-immunity booster to established intramuscular respiratory vaccine franchises, using its clinically validated Nm-nOMV platform derived from Neisseria meningitidis outer membrane vesicles.

The paper, titled 'Boosting mRNA: Mucosal Immunity and a Platform Beyond It,' outlines a heterologous prime-boost regimen: existing intramuscular vaccines would prime systemic immunity, while an intranasal Nm-nOMV dose would generate complementary IgA responses at the respiratory mucosa, the initial entry point for pathogens.

PlanetiQ Wins Spot on NOAA's New $Multi-Year SBEM Satellite Data Contract

Image
PlanetiQ Wins Spot on NOAA's New $Multi-Year SBEM Satellite Data Contract

Golden, Colo. – September 17, 2026 -- PlanetiQ has been named an industry partner under NOAA's new Space-Based Environmental Monitoring (SBEM) Indefinite Delivery, Indefinite Quantity contract, a vehicle running from September 17, 2026, through September 17, 2026, with a five-year base period and a five-year option.

NOAA opens new decade-long contract vehicle for commercial satellite data

The SBEM IDIQ, established by NOAA's National Environmental Satellite, Data, and Information Service (NESDIS) through its Commercial Data Program, will let PlanetiQ compete for task orders covering two data types: Global Navigation Satellite System-Radio Occultation (GNSS-RO) observations for atmospheric and ionospheric monitoring, and thermospheric neutral density data for satellite orbit prediction.

Bloomberg Tax Projects 3.2% Inflation Rise for 2027 Tax Brackets

Image
Bloomberg Tax Projects 3.2% Inflation Rise for 2027 Tax Brackets

Arlington, Va. – September 17, 2026 -- Bloomberg Tax & Accounting has projected a 3.2% inflation increase for 2027, up from the 2.7% rise recorded for 2026, according to its newly released 2027 Projected U.S. Tax Rates report.

Bureau of Labor Statistics data gap forces 11-month calculation method

The Bureau of Labor Statistics failed to report October 2025 data, an unprecedented lapse that required Bloomberg Tax to compute the Chained Consumer Price Index for All Urban Consumers (C-CPI-U) using an 11-month average instead of the standard 12-month period.

TSA Marks 25th Anniversary, Launches Horizon 25 Modernization Strategy

Image
TSA Marks 25th Anniversary, Launches Horizon 25 Modernization Strategy

Washington – September 17, 2026 -- The Transportation Security Administration marked the 25th anniversary of the September 17, 2026 attacks by launching its Horizon 25 Strategy, a modernization push covering all transportation modes under the Trump administration and Secretary Mullin.

TSA traces its origin to the Aviation and Transportation Security Act signed into law on September 17, 2026

President George W. Bush created the agency in direct response to the attacks that killed nearly 3,000 people, tasking it with restoring confidence in the aviation system and safeguarding freedom of movement for people and commerce.

Administrator David P. Cummins says the agency must modernize against sophisticated, evolving threats

"TSA must modernize to defend against those threats," Cummins said, framing Horizon 25 as the vehicle to advance capabilities across all modes of transportation and ensure a September 11 attack "never happens again."

Cryovials Market to Hit $0.31B by 2031 on Cell Therapy Demand

Image
Cryovials Market to Hit $0.31B by 2031 on Cell Therapy Demand

Delray Beach, Fla. – September 17, 2026 -- The global cryovials market is projected to grow from $0.24 billion in 2026 to $0.31 billion by 2031, expanding at a compound annual growth rate of 5.5%, according to MarketsandMarkets.

Cell and gene therapy demand drives fastest-growing application segment

The cell and gene therapy segment is set to register the highest CAGR among applications at 8.0%, fueled by expanding commercialization of CAR-T cell therapies, stem cell treatments, and gene-modified therapies. These advanced therapies require secure cryogenic storage across collection, processing, manufacturing, transportation, and administration to preserve cell viability. Manufacturers scaling from clinical to commercial production are prioritizing sterile, barcoded cryovials with secure closure systems compatible with automated storage.

Ohio Inspectors Find Overcharging at 36% of Kroger Stores Audited

Image
Ohio Inspectors Find Overcharging at 36% of Kroger Stores Audited

Cincinnati – September 17, 2026 -- Government inspectors found overcharging at more than one in three Kroger stores examined across nine Ohio jurisdictions, according to a report released this week by the Center for Responsible Food Business (CRFB). Pricing errors favored Kroger nearly three times as often as they favored shoppers.

Inspection records show 58 of 389 store checks failed between 2022 and mid-2026

The public-records data, covering nine Ohio jurisdictions, documented 644 incorrect prices during 389 inspections. Overcharges averaged more than 20 percent above posted shelf prices, and 36 of 101 stores examined were caught overcharging at least once.

Husqvarna First to Win FCC Approval for Foreign-Made Robotic Mowers

Stockholm – September 17, 2026 -- Husqvarna Group has become the first robotics company to secure Conditional Approval from the U.S. Federal Communications Commission (FCC) for foreign-manufactured advanced robotic devices, clearing a key regulatory hurdle for its U.S. expansion.

FCC exempts four Husqvarna mower platforms from national security covered list

The FCC's Public Safety and Homeland Security Bureau announced the approval on September 17, 2026, covering four Automower platforms: the 305V iQ, 310V iQ, 420V iQ and 440V iQ. The decision follows the FCC's August 2026 publication of a covered list identifying communications equipment deemed a national security risk; the Conditional Approval exempts these specific Husqvarna platforms, along with models already sold in the U.S., from that list.

iGan Partners' Portfolio Lands $70M BARDA Deal, 166% Revenue Growth

Image
iGan Partners' Portfolio Lands $70M BARDA Deal, 166% Revenue Growth

Toronto – September 17, 2026 -- iGan Partners, a Toronto-based venture capital firm focused on medical device, diagnostic, imaging, and digital health companies, disclosed a series of portfolio milestones, headlined by a development contract worth up to $70 million awarded to portfolio company Flosonics Medical.

Flosonics secures BARDA contract to extend ultrasound tech into trauma care

The contract, from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, includes approximately $15 million in initial funding. It supports FloPredict, an AI-enabled software enhancement to Flosonics' FDA-cleared FloPatch device, expanding the real-time ultrasound technology into trauma care and mass casualty response applications.

Eloxx Doses First Patients in Phase 2b Alport Syndrome Trial

Image
Eloxx Doses First Patients in Phase 2b Alport Syndrome Trial

Arlington, Mass. – – September 17, 2026 -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) has dosed the first two patients in the EXACT Study, a Phase 2b trial evaluating its investigational drug exaluren in patients with nonsense mutation Alport syndrome (NMAS), a rare kidney disease with no FDA-approved therapy targeting its genetic cause.

Trial targets 24 patients with a 16-week placebo-controlled start

The global, randomized, delayed-start Phase 2b trial will enroll 24 patients carrying nonsense mutations in the COL4A3, COL4A4, or COL4A5 genes. The initial 16-week placebo-controlled portion measures the drug's effect on structural podocyte changes via foot process effacement, assessed through kidney biopsies in non-U.S. pediatric patients and all adult participants.